[Antiviral properties of polynucleotides not associated with interferon induction].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D002478:Cells, Cultured; D004247:DNA / Q000627:therapeutic use; D005814:Genes, Viral / Q000187:drug effects; D007369:Interferon Inducers / Q000494:pharmacology* / Q000627:therapeutic use; D008264:Macrophages / Q000187:drug effects; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011131:Polyribonucleotides / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D012313:RNA / Q000627:therapeutic use; D012335:RNA, Ribosomal / Q000627:therapeutic use; D012343:RNA, Transfer / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D014777:Virus Diseases / Q000276:immunology; D014779:Virus Replication / Q000187:drug effects
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D007369:Interferon Inducers; D011131:Polyribonucleotides; D012335:RNA, Ribosomal; D012313:RNA; D004247:DNA; D012343:RNA, Transfer
Antivirusnye svoĭstva polinukleotidov, na sviazannye s induktsieĭ interferona.